Japan unit of Britain’s Jazz Pharma starts phase III trial of cannabis drug – Reuters
TOKYO, Dec 15 (Reuters) – The Japanese unit of Britain’s Jazz Pharmaceuticals PLC (JAZZ.O) said on Thursday it had started a phase III trial of a cannabis-based drug for epilepsy.
The trial follows …